Evogene Ltd. (EVGN) vs Kairos Pharma, Ltd. (KAPA)

Evogene Ltd. and Kairos Pharma, Ltd. are both Biotechnology companies. Evogene Ltd. and Kairos Pharma, Ltd. are of similar size ($6.3M and $6.1M). Kairos Pharma, Ltd. has the higher net margin (0.00% vs −547.6%) and the lower return on invested capital (−322.9% vs 0.00%). Across the 12 metrics below, Evogene Ltd. leads on 6 and Kairos Pharma, Ltd. on 6.

Valuation

Metric EVGN KAPA Biotechnology median
P/E n/m n/m 7.88
P/S 3.09 n/m 11.47
P/B 0.89 1.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.39 n/m 0.74
EV/Sales (2.55) n/m 10.73
Earnings yield (216.67%) (113.92%) (28.84%)
Free cash flow yield (210.40%) (75.40%) (23.03%)

Profitability

Metric EVGN KAPA Biotechnology median
Gross margin (67.59%) — 65.16%
Operating margin (851.42%) 0.00% 0.00%
Net margin (547.62%) 0.00% 0.00%
Free cash flow margin (650.63%) 0.00% 0.00%
Return on equity (100.03%) (113.96%) (57.72%)
Return on assets (38.31%) (104.32%) (49.22%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric EVGN KAPA Biotechnology median
Revenue growth (TTM) (54.71%) — 5.64%
EPS growth (last fiscal year) 62.63% (30.44%) —
Revenue growth, 5-year CAGR 29.94% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric EVGN KAPA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.57 11.98 4.73
Net debt to EBITDA 1.12 1.65 0.96

Dividend

Metric EVGN KAPA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric EVGN KAPA Biotechnology median
Market cap 6.32m 6.13m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack